Genomic Evolution After Chemoradiotherapy in Anal Squamous Cell Carcinoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-2017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Oxygen-Enhanced MRI MOLLI T1 Mapping During Chemoradiotherapy in Anal Squamous Cell Carcinoma

Clinical and Translational Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2020English

Squamous Cell Carcinoma of the Anal Canal

2020English

Chemoradiotherapy of Locally-Advanced Anal Canal Squamous Cell Carcinoma: A Brief Review of Outcomes of Randomized Clinical Trials

Journal of Medical Science And clinical Research
2019English

The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma After Concurrent Chemoradiotherapy

Cancer Research and Treatment
Cancer ResearchOncology
2016English

1026 Assessment of Novel Biomarkers in Anal Squamous Cell Carcinoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of the Oropharynx

Journal of Otolaryngology of Japan
Otorhinolaryngology
2007English

Lymph Node Enlargement After Definitive Chemoradiotherapy for Clinical Stage I Esophageal Squamous Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Complete Pathologic Response After Chemoradiotherapy in a Patient With Rectal Squamous Cell Carcinoma: A Case Report

Cancer Biology and Medicine
Cancer ResearchOncology
2017English

The Axis “Human Papillomavirus - Anal Squamous Cell Carcinoma”: A Review

Medical Technologies Journal
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy